Covalent Modifiers
@CovalentMod
A feed for the blog http://covalentmodifiers.blogspot.com. Discusses the covalent modification of proteins. Available on bsky and mass std don
You might like
FYI, the code that tweets out notices of new posts stopped working some months ago. If you'd like to continuing following this content, subscribe to the blog feed directly or follow us on bsky.
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers covalentmodifiers.blogspot.com/2025/05/zonger…
Design, synthesis and biological evaluation of the activity-based probes for FGFR covalent inhibitor covalentmodifiers.blogspot.com/2025/05/design…
Discovery of a Novel Serine-Targeting Covalent Inhibitor against HCES2A for Treating Drug-induced Diarrhea and Ulcerative Colitis covalentmodifiers.blogspot.com/2025/05/discov…
Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of the mitophagy regulator USP30 covalentmodifiers.blogspot.com/2025/05/chimer…
Blocking C-terminal processing of KRAS4b via a direct covalent attack on the CaaX-box cysteine covalentmodifiers.blogspot.com/2025/05/blocki…
Discovery of Carbodiimide Warheads to Selectively and Covalently Target Aspartic Acid in KRASG12D covalentmodifiers.blogspot.com/2025/05/discov…
Residue-Selective Inhibitors Discovery via Covalent DNA-Encoded Chemical Libraries with Diverse Warheads covalentmodifiers.blogspot.com/2025/05/residu…
Glecirasib, a potent and selective covalent KRAS G12C inhibitor exhibiting synergism 2 with cetuximab or SHP2 inhibitor JAB-3312 covalentmodifiers.blogspot.com/2025/05/glecir…
Clinical update for zoldonrasib - Ras(on)G12D selective covalent inhibitor - dosed at 1200 mg qd po (MTD previously not reached). Generally well tolerated, 89% disease control rate for NSCLC patients, two promising case studies shared, but still very early days. #AACR25 @AACR
Discovery and Optimization of a Covalent AKR1C3 Inhibitor covalentmodifiers.blogspot.com/2025/04/discov…
DCAF16-Based Covalent Degradative Handles for the Modular Design of Degraders covalentmodifiers.blogspot.com/2025/04/dcaf16…
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Identify Covalent TLCD1 Inhibitors covalentmodifiers.blogspot.com/2025/04/proteo…
Discovery and Optimization of a Covalent AKR1C3 Inhibitor covalentmodifiers.blogspot.com/2025/04/discov…
Discovery of RNA-Reactive Small Molecules Guides Design of Electrophilic Modules for RNA-Specific Covalent Binders covalentmodifiers.blogspot.com/2025/04/discov…
Identification of a phenyl ester covalent inhibitor of caseinolytic protease and analysis of the ClpP1P2 inhibition in mycobacteria covalentmodifiers.blogspot.com/2025/04/identi…
Substrate Trapping in Polyketide Synthase Thioesterase Domains: Structural Basis for Macrolactone Formation covalentmodifiers.blogspot.com/2025/04/substr…
Covalent Modification of Glutamic Acid Inspired by HaloTag Technology covalentmodifiers.blogspot.com/2025/04/covale…
If you'd like to follow Covalent Modifier content on LinkedIn, our "company page" is online linkedin.com/company/covale…
A predictive model for thiol reactivity of N-heteroaryl α-methylene–γ-lactams—a medicinally relevant covalent reactive group covalentmodifiers.blogspot.com/2025/04/a-pred…
United States Trends
- 1. Giants 73.9K posts
- 2. Giants 73.9K posts
- 3. #WWERaw 60K posts
- 4. Patriots 107K posts
- 5. Drake Maye 19.1K posts
- 6. Dart 30.9K posts
- 7. Diaz 33.6K posts
- 8. Gunther 12.7K posts
- 9. Devin Williams 6,620 posts
- 10. Dillon Brooks 1,381 posts
- 11. Younghoe Koo 5,293 posts
- 12. Ryan Nembhard 1,049 posts
- 13. Mets 17.5K posts
- 14. Joe Schoen 2,377 posts
- 15. Abdul Carter 8,919 posts
- 16. Kafka 7,484 posts
- 17. LA Knight 12.6K posts
- 18. Theo Johnson 1,947 posts
- 19. #RawOnNetflix 1,904 posts
- 20. Marcus Jones 5,746 posts
You might like
-
Stuart Schreiber
@SchreiberStuart -
drug hunter
@drughunter_com -
Alessio Ciulli
@alessiociulli -
Dan Nomura
@DanNomura -
Guillaume Laconde
@Glaconde34 -
Ingo Hartung
@HartungIngo -
Katherine A Donovan
@kdonovan1008 -
C4 Therapeutics
@C4Therapeutics -
Ryan Potts
@pottslab -
Darryl B McConnell
@D_B_McConnell -
Woo Lab
@thewoolab -
Laura Kiessling
@ChemicalBiology -
Cell Chemical Biology
@CellChemBiol -
Practical_Fragments
@PracticalFrag -
ChemBioChem
@ChemBioChem
Something went wrong.
Something went wrong.